(CIDRAP News) – The Swiss pharmaceutical company Roche announced today it is scaling back production of oseltamivir (Tamiflu) because of waning demand, and simultaneously questioned whether countries stockpiling the drug are buying enough to protect their citizens in the event of an influenza pandemic.
(CIDRAP News) European countries' plans for coping with an influenza pandemic are generally good but have a number of gaps, including a lack of detail on distribution of drugs and supplies, according to an analysis published last week by The Lancet.
(CIDRAP News) The Swiss drug company Roche has pledged to give the World Health Organization (WHO) enough doses of the antiviral drug oseltamivir (Tamiflu) to treat 3 million people, in the hope that it could help to stave off or delay an influenza pandemic.
(CIDRAP News) The World Health Organization's top influenza expert warned at the end of a 2-day international meeting today that governments need to fund the development of vaccines to combat a feared flu pandemic that could kill millions of people, according to news services.
(CIDRAP News) – The World Health Organization (WHO) has called a Nov 11 "summit" meeting of health officials and vaccine companies to discuss how to confront what is seen as the growing risk that avian influenza will trigger a human flu pandemic.